SG11202103058PA - Preventive and/or therapeutic agent for clostridium difficile infection - Google Patents

Preventive and/or therapeutic agent for clostridium difficile infection

Info

Publication number
SG11202103058PA
SG11202103058PA SG11202103058PA SG11202103058PA SG11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA SG 11202103058P A SG11202103058P A SG 11202103058PA
Authority
SG
Singapore
Prior art keywords
preventive
therapeutic agent
clostridium difficile
difficile infection
infection
Prior art date
Application number
SG11202103058PA
Other languages
English (en)
Inventor
Susumu Kawaguchi
Miho Kato
Original Assignee
Nutri Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutri Co Ltd filed Critical Nutri Co Ltd
Publication of SG11202103058PA publication Critical patent/SG11202103058PA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
SG11202103058PA 2018-10-10 2019-10-04 Preventive and/or therapeutic agent for clostridium difficile infection SG11202103058PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018191488 2018-10-10
PCT/JP2019/039254 WO2020075637A1 (fr) 2018-10-10 2019-10-04 Agent prophylactique et/ou thérapeutique contre les infections à clostridium difficile

Publications (1)

Publication Number Publication Date
SG11202103058PA true SG11202103058PA (en) 2021-04-29

Family

ID=70163989

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103058PA SG11202103058PA (en) 2018-10-10 2019-10-04 Preventive and/or therapeutic agent for clostridium difficile infection

Country Status (9)

Country Link
US (1) US11730776B2 (fr)
EP (1) EP3865140A4 (fr)
JP (1) JP7369709B2 (fr)
KR (1) KR20210073531A (fr)
CN (1) CN112823014A (fr)
AU (1) AU2019358838A1 (fr)
CA (1) CA3113221A1 (fr)
SG (1) SG11202103058PA (fr)
WO (1) WO2020075637A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3574910A4 (fr) * 2017-01-30 2020-10-21 Nutri Co., Ltd. Agent de protection contre une infection par le sarm
EP4119150A1 (fr) * 2020-03-13 2023-01-18 Nutri Co., Ltd. Inhibiteur de croissance de clostridiodes difficile
KR102617297B1 (ko) * 2020-08-21 2023-12-27 서울대학교산학협력단 클로스트리디움 디피실리 감염의 치료 또는 예방용 조성물
CA3229107A1 (fr) * 2021-08-27 2023-03-02 Nutri Co., Ltd. Agent pour la prevention et/ou le traitement d'une infection par porphyromonas gingivalis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002179580A (ja) * 2000-12-13 2002-06-26 Zenwa Gu プロポリス抽出物、ロイヤルゼリー、及びエンテロコッカス・フェカリス死菌体を含んでなる医薬
JP2003261453A (ja) * 2002-03-11 2003-09-16 Nippon Berumu Kk E.フェカリスからなる抗腫瘍剤及び放射線防護剤
US20050266069A1 (en) * 2002-09-06 2005-12-01 Simmons Donald L Stable probiotic microsphere compositions and their methods of preparation
JP5308619B2 (ja) * 2006-06-05 2013-10-09 株式会社アドバンス 健康食品
US10973861B2 (en) * 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
WO2016065279A1 (fr) * 2014-10-23 2016-04-28 Symbiotic Health Inc. Capsule pour l'administration par voie orale de produits biopharmaceutiques
AU2017238644B2 (en) * 2016-03-24 2022-12-15 Paratek Pharmaceuticals, Inc. Methods for treating and preventing C. difficile infection
EP3574910A4 (fr) * 2017-01-30 2020-10-21 Nutri Co., Ltd. Agent de protection contre une infection par le sarm
JP6383458B1 (ja) 2017-05-11 2018-08-29 西芝電機株式会社 回転電機
IT201700101704A1 (it) * 2017-09-12 2019-03-12 Sofar Spa Nuovo uso per trattamento delle infezioni da clostridium difficile

Also Published As

Publication number Publication date
US20210386797A1 (en) 2021-12-16
JP7369709B2 (ja) 2023-10-26
JPWO2020075637A1 (ja) 2021-09-16
EP3865140A8 (fr) 2022-05-18
EP3865140A4 (fr) 2022-11-09
WO2020075637A1 (fr) 2020-04-16
CA3113221A1 (fr) 2020-04-16
CN112823014A (zh) 2021-05-18
US11730776B2 (en) 2023-08-22
EP3865140A1 (fr) 2021-08-18
KR20210073531A (ko) 2021-06-18
AU2019358838A1 (en) 2021-04-15

Similar Documents

Publication Publication Date Title
MX2023003461A (es) Tratamiento de infeccion por clostridium difficile.
SG11202103058PA (en) Preventive and/or therapeutic agent for clostridium difficile infection
IL276883A (en) "Compositions, devices, systems, kits and methods for treating skin conditions"
IL257687B (en) Bleeding valve for medical device introducer
SG10201913559VA (en) Methods for treating and preventing c. difficile infection
SG11202003539VA (en) Compositions and methods for treating liberibacter diseases and other bacterial diseases
HK1249515A1 (zh) 預防和治療聽力損失的方法和組合物
SG11202012055PA (en) Methods and compositions for preventing or treating calciphylaxis
ZA201701671B (en) Novel pharmaceutical composition for prevention and/or treatment of urinary incontinence
HK1254532A1 (zh) 面向嬰兒的感染防禦劑
IL284462A (en) Tissue treatment systems and methods
PT3120852T (pt) Agente preventivo e/ou terapêutico para doenças imunitárias
PT3810128T (pt) Composições para tratar e/ou prevenir doenças de agregação de proteinas
EP3636266A4 (fr) Inhibiteur de maladies de la peau, et composition pour l'inhibition de maladies de la peau
EP3648654A4 (fr) Procédés, compositions et dispositifs destinés à des procédures gynécologiques
EP3581204A4 (fr) Agent préventif et/ou thérapeutique contre des maladies infectieuses ou inflammatoires
EP3609578A4 (fr) Combinaison pharmaceutique et son utilisation pour le traitement de synucléinopathies
EP3574918A4 (fr) Agent thérapeutique ou prophylactique, et méthode de traitement ou de prévention du syndrome d'irradiation aiguë
EP3773582C0 (fr) Agent anti-cancéreux sélectif efficace pour la prévention et le traitement
EP3146975A4 (fr) Agent de prévention et de traitement de l'infection à chlamydia
EP3747407A4 (fr) Dispositif de protection pour endoprothèse et dispositif médical
SI3758799T1 (sl) Sestava za preprečevanje in zdravljenje poškodb kože, ki jih povzroča izpostavljenost svetlobnemu sevanju
RS65225B1 (sr) Lek za lečenje i/ili prevenciju endometrioze
HUE066272T2 (hu) Terápiás szer az amiotrófiás laterálszklerózisra és a kezelésre szolgáló készítmény
SG11202007250UA (en) Urolith removal and prevention agent